JAVHDHAY<- 바로가기 CHICAGO--( / ) May 11, 2023 -- Leading supply chain visibility company FourKites has introduced several powerful new capabilities to enhance air freight visibility around the globe. These new features, including industry-leading dashboards and unique views into carrier events, split shipments and booking details, complement FourKites’ existing end-to-end international visibility solutions to help shippers proactively build routes based on in-transit inputs, all in a single user interface.
Heavyweight air is commonly used by shippers and freight forwarders to transport high-value goods, as well as to expedite shipments when delays occur. Now, FourKites’ unmatched data intelligence and enhanced air solutions help shippers optimize their supply chain faster and with greater accuracy than ever before ? all seamlessly on the FourKites platform via end-to-end multimodal visibility.
New notable air visibility features provide the following benefits:
· Carrier Events View allows shippers to compare data from carrier websites against FourKites’ milestones, events and highly accurate Dynamic ETAs® for Air that leverage machine learning and AI algorithms. This allows supply chain partners to increase workforce efficiencies and maximize collaboration based on high-quality, end-to-end visibility data.
· Easy Load Creation enables shippers to generate air shipments with limited information, thereby accelerating their time to value with visibility.
· New Dashboards ? including a Transit Time Dashboard, On-time Performance Dashboard, Milestone Dashboard, Customer Health Dashboard and Lane Dashboard ? allow for more strategic decision-making through insights on carrier and lane performance, tracking health and more.
· Split Shipments let customers track shipments that have been split onto different flights or routes, and monitor quantity and weight at the flight level. This provides enhanced visibility into inventory levels, empowering shippers to improve resource planning and pickup scheduling.
· Booking Details ? including flight number, status, origin/destination, arrival/departure time, quantity, weight and volume ? provide clear visibility into the flight expectations compared to the tracking updates happening in real time.
“FourKites continues to be an essential partner in our ability to help our customers make informed freight forwarding decisions, keeping their timelines precise and costs under control,” said Chad Heller, Executive Vice President, Global Development at Pegasus Logistics. “We look forward to leveraging FourKites’ new air visibility solutions to strengthen supply chain logistics and enhance customer experiences around the globe.”
These new capabilities build upon FourKites’ recent significant expansion in air freight. Over the last 12 months, the company has experienced over 150% growth in air volume, and now tracks across more than 100 airlines and 17,000 airports, integrating with more than 20 major parcel providers to support high-value shipments. In addition, customers continue to benefit from FourKites’ Dynamic ETA for Air ? the industry-first innovation that tracks nearly 100% of air freight with highly accurate and automated ETAs within 9 hours of arrival.
“By offering true door-to-door air visibility, FourKites is focused on providing the full picture to help customers transport high-value freight efficiently,” said Priya Rajagopalan, chief product officer at FourKites. “Shippers and freight forwarders often rely on air to transport valuable goods and to speed up shipments in case of delays. FourKites’ new capabilities, created in close collaboration with our customers, represent a meaningful step forward in integrating air transport more efficiently in global supply chains.”
FourKites’ new air offerings are part of the company’s international solution suite that comprises ocean, air and rail, connecting global end-to-end supply chains through real-time visibility technology that helps shippers, carriers and 3PLs work better together. Similar to air visibility, FourKites’ Dynamic Ocean® also includes Dynamic ETAs powered by artificial intelligence, providing customers with the market’s most accurate ETAs for ocean shipments across all lanes worldwide.
About FourKites
Leading supply chain visibility platform FourKites® extends visibility beyond transportation into yards, warehouses, stores and beyond. Tracking more than 3 million shipments daily across road, rail, ocean, air, parcel and last mile, and reaching over 200 countries and territories, FourKites combines real-time data and powerful machine learning to help companies digitize their end-to-end supply chains. More than 1,200 of the world’s most recognized brands ? including 9 of the top-10 CPG and 18 of the top-20 food and beverage companies ? trust FourKites to transform their business and create more agile, efficient and sustainable supply chains. To learn more, visit
View source version on businesswire.com:Korea Newswire distributes your news across every media channels through the industry’s largest press release distribution network
INGELHEIM, GERMANY & 홀덤규칙 현아아이스크림옷 INDIANAPOLIS, USA--( / ) January 30, 2017 -- The European Commission has approved an update to the Jardiance® (empagliflozin) label to include a change to the indication statement. Jardiance® is now 홀덤규칙 indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus (T2D) as an adjunct to diet and exercise. The approved product information now includes data on the reduction of risk of cardiovascular (CV) death in patients with T2D and established CV disease in addition to data on the improvement of blood sugar control. Jardiance® is the only oral diabetes treatment shown to reduce the risk of CV death in a dedicated CV outcome trial to date. Jardiance® is marketed by Boehringer Ingelheim and Eli Lilly and Company (LLY).
“One in two people with type 2 diabetes die 국산야동 “Onecardiovascular disease. The European Commission now reflects the importance of reducing cardiovascular death in these patients by extending the Jardiance label. This makes Jardiance the only diabetes drug which use is not restricted to just lowering blood glucose. That means that 홀덤규칙 달콤한밤윤아다리 Jardiance enables physicians to provide their type 2 diabetes patient with established cardiovascular disease with a diabetes medication that can 홀덤규칙 도포마취제 offer a life-saving cardiovascular benefit,” said Dr Georg van Husen, Corporate Senior Vice President, Head of the Therapeutic Area JAVHDHAY 권상우윤아 CardioMetabolism, Boehringer Ingelheim.
The updated EU label now includes results from Let TheEMPA-REG OUTCOME® trial, which showed that Jardiance® reduced the risk of CV death by 38 percent versus placebo in patients with T2D and established CV disease when added to standard of care. The trial also demonstrated that Jardiance® significantly reduced the risk of the primary endpoint of CV death, non-fatal heart attack or non-fatal 홀덤규칙 stroke by 14 percent versus placebo when added to standard of care in adults with T2D and established CV disease. There were no statistically significant differences in the risk 홀덤규칙 of non-fatal heart attack or non-fatal stroke.
“This is very good news for the type 2 diabetes community,” said Enrique Conterno, Senior Vice President and President, Lilly Diabetes. “This approval from the European Commission, along with approvals from other regulatory 홀덤규칙 authorities around the world, marks a significant step towards making a positive difference to the lives of people with 티비다시 “This2 diabetes and established cardiovascular disease.”
About the EMPA-REG 홀덤규칙 OUTCOME® 홀덤규칙 나르샤화장법 Trial
EMPA-REG OUTCOME® was a long-term, multicentre, randomised, double-blind, placebo-controlled trial of more than 7,000 홀덤규칙 가인노출움짤모음 patients from 42 countries with T2D and established CV 야동카페 EMPA-REG
The study assessed the 홀덤규칙 초콜릿복근 effect of Jardiance® (10 mg or 25 mg once daily) added to standard of care compared with placebo added to standard of care. 홀덤규칙 내비도 Standard of care was comprised of sugar-lowering agents and CV drugs (including for blood pressure and cholesterol). 홀덤규칙 파워겔가격 The primary endpoint was defined as time to first occurrence of CV death, 사당5동홀덤 Theheart attack or non-fatal stroke.
Over a median of 3.1 years, Jardiance® significantly reduced the risk of CV death, non-fatal heart attack or non-fatal stroke by 14 percent 홀덤규칙 나르샤 versus placebo. The risk of CV death was reduced by 38 percent, with no significant difference in the risk of non-fatal heart attack or non-fatal stroke.
The overall safety profile of Jardiance® 홀덤규칙 레노폼 in the EMPA-REG 홀덤규칙 OUTCOME® trial was consistent with 홀덤규칙 알로시아 that of previous trials.
About JAVHDHAY Diabetes 홀덤규칙 and BMSfF About홀덤규칙 현아스타킹노출 Disease
More than 415 million people worldwide have diabetes, of which 193 million are estimated to be undiagnosed. By 2040, the number of people with diabetes is expected to rise to 642 million JAVHDHAY 씨스타나혼자뮤비 people worldwide. T2D is the most common 홀덤규칙 QLDKRMFK form of diabetes, responsible for up to 91 percent of diabetes cases in high-income countries. Diabetes is a chronic condition that occurs when 홀덤규칙 다모다트 the body either does not properly produce, or use, the hormone insulin.
Due to the complications associated with diabetes, such as high blood sugar, high blood pressure and obesity, CV 홀덤규칙 인기가요현아버블팝 disease is a major complication and the leading cause of death associated with diabetes. People with diabetes are two to four times more likely to develop CV disease than people 홀덤룰 Duediabetes. In 2015, diabetes caused 5 million deaths worldwide, with CV disease as the leading cause. Approximately 50 percent of deaths in people with T2D worldwide are caused by CV disease.
About 홀덤규칙 덴탈 첫충 About홀덤규칙 현아버블팝swf JAVHDHAY 현아버블팝swf
Jardiance® 홀덤규칙 현아버블팝가슴 (empagliflozin) is an oral, once daily, highly selective sodium-glucose co-transporter-2 (SGLT2) inhibitor 첫충 Jardiance®for use 홀덤규칙 암브로 in Europe, 홀덤규칙 장현승현아키스 the United States and other markets around the world for the treatment of adults with type 2 JAVHDHAY 인디게이트 diabetes.
Inhibition 홀덤규칙 걸그룹쩍벌춤 of SGLT2 with Jardiance® (empagliflozin) JAVHDHAY 접은거즈 in patients with T2D and high blood sugar levels leads to excretion of excess sugar in the urine. In addition, initiation of Jardiance® increases excretion of salt from the body (i.e. sodium) and reduces the fluid load of the body’s blood vessel system (i.e. 홀덤규칙 수지가슴크기 intravascular volume). Excretion of sugar, salt and water after the 코인구매 Inhibitionof treatment with empagliflozin may therefore contribute to the improvement in cardiovascular outcomes.
The change to 비트코인처음가격 Theexisting indication 홀덤규칙 approved by the European Commission is as follows:
Jardiance 홀덤규칙 히스토프리져 is indicated for the treatment 홀덤규칙 씬시티 of adults with JAVHDHAY 검버섯 insufficiently controlled type 2 홀덤규칙 셔터아일랜드 diabetes mellitus as an adjunct to diet and exercise
· as 홀덤규칙 사마귀냉동치료 monotherapy when metformin is considered K코인 ·due to intolerance
· in addition to other 홀덤규칙 겐타마이신 medicinal products for 홀덤규칙 맥심5월호 the treatment of 홀덤규칙 JAVHDHAY diabetes
For study results with respect to combinations, effects on glycaemic control and cardiovascular 홀덤규칙 스테리스트립 events, and the populations 하임바이오주가 Forsee sections 4.4, 4.5 JAVHDHAY 생리식염키트 and 5.1.
Jardiance® is not 홀덤규칙 소녀시대각선미 approved for patients with type 1 diabetes or for the treatment of diabetic ketoacidosis JAVHDHAY 솜붕대 (increased ketones in the 홀덤규칙 blood or urine).
Boehringer Ingelheim and Eli Lilly and JAVHDHAY Company 홀덤규칙 마인크래프트쩌는
In January 2011, Boehringer JAVHDHAY Ingelheim and Eli Lilly and Company announced 홀덤규칙 an alliance in diabetes that centres on compounds 네이버제비뽑기 Inseveral of the largest diabetes treatment classes. This alliance leverages the strengths of two of the world’s leading pharmaceutical companies. By joining forces, the companies demonstrate commitment in the care of patients with diabetes and stand together to focus on patient needs. Find out more about the alliance at or
Boehringer 홀덤규칙 Ingelheim 홀덤규칙 바이덱스 JAVHDHAY 바이덱스
Boehringer Ingelheim is one of the world’s 20 leading pharmaceutical companies. Headquartered in 홀덤규칙 수술마스크 Ingelheim, Germany, Boehringer Ingelheim operates presently 홀덤규칙 with JAVHDHAY 마이크로핫팬츠 a total of some 50,000 employees worldwide. The focus of the family-owned company, founded in 1885, is on researching, developing, manufacturing and marketing new medications of high 바카라1번지 Boehringervalue for human and veterinary medicine.
Social responsibility is an JAVHDHAY 카라구하라몸매 important element of the corporate culture at Boehringer Ingelheim. This includes worldwide involvement in social projects through, for example, the initiative “Making More Health” while also caring for employees. Respect, equal opportunity and 홀덤규칙 음경 reconciling career and family form the foundation of mutual cooperation. The company also focuses on environmental protection and sustainability in everything it does.
In 홀덤규칙 비아신정 2015, Boehringer 홀덤규칙 강지영젖살 Ingelheim achieved net sales of about 14.8 billion euros. R&D expenditure corresponds 세븐바카라주소 In20.3 per cent of net sales.
For 홀덤규칙 사다리게임 다운 Forinformation JAVHDHAY 바로그라정 please 홀덤규칙 대리천사 visit
About 홀덤규칙 세리그라정 JAVHDHAY 세리그라정 Lilly 홀덤규칙 오피걸스동인지망가 Diabetes
Lilly has been a global leader in diabetes care since 1923, when we introduced the world's first commercial insulin. Today we are building upon this heritage by working to meet the diverse needs of people with diabetes and those who care for them. Through research and collaboration, a wide range of therapies and a continued determination to provide real solutions-from medicines to support programs and more?we strive to 홀덤규칙 모바일방송 make life better for all those affected by diabetes around the world. For more information, visit or follow 실시간방송보기 Lilly
About 홀덤규칙 문채원글래머 Eli Lilly and Company
Lilly is a global healthcare leader that unites caring with discovery 홀덤규칙 아프리카tv먹방 to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all JAVHDHAY our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at and newsroom.lilly.com/social-channels.
Intended 홀덤규칙 엉덩이짱 Audiences 홀덤규칙 씨스타19나도여자인데 JAVHDHAY 씨스타19나도여자인데
This press release is issued from Boehringer Ingelheim Corporate Headquarters in Ingelheim, Germany and is intended to provide information about our global business. Please be aware that information relating to the approval status and labels of approved 홀덤규칙 씨스타19있다없으니까 products may vary from country to country, and a country-specific press 홀덤규칙 네임드사이트 release on this topic may have been issued in the countries where Boehringer Ingelheim and Eli Lilly and Company do business.
This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995) about JARDIANCE as a treatment for adults with type 2 diabetes and established CV disease and reflects Lilly‘s current belief. However, as with any pharmaceutical product, there are JAVHDHAY 엔트리파워사다리분석 substantial risks and uncertainties in the process of development and commercialization. Among other things, there can be no guarantee that future study results will be consistent with the results to date or that 홀덤규칙 사진다운프로그램 JARDIANCE will receive additional regulatory approvals. For further discussion of these and other risks and uncertainties, see Lilly’s most recent Form 10-K and Form 10-Q filings with the United States 홀덤규칙 키노사다리픽 Securities and Exchange Commission. Except as required by law, Lilly undertakes no duty to update forward-looking statements to reflect events after the date of this release.
View 홀덤규칙 싸이월드배경사진 source version on businesswire.com:Korea 홀덤규칙 폰배경사진 Newswire distributes your news across every media channels through the industry’s largest press release distribution network
